PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia

Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY

Recorded on May 20, 2022

Gwen L. Nichols, MD
Gwen L. Nichols, MD
Chief Medical Officer
The Leukemia & Lymphoma Society
Rye Brook, NY

Through the LLS Children’s Initiative, The Leukemia & Lymphoma Society (LLS) is setting out to fundamentally change how children with blood cancer are treated and cared for. For children and their families, LLS provides free education, support services, financial assistance, advocacy efforts, and has increased its research investments in childhood blood cancer. As part of this initiative, LLS PedAL, a first-of-its-kind global master clinical trial for pediatric acute leukemia patients, will fundamentally change how children are treated. In this episode, Dr. Gwen Nichols, EVP and Chief Medical Officer joins us to discuss PedAL, including sharing reflections on lack of pediatric ALL and AML therapies that led to the development of this master clinical trial. Dr. Nichols discusses challenges in creating pediatric therapies, the importance of data collection and creating a standard of care, and the ultimate impact PedAL will have on all clinical trials moving forward. Tune in today!

Leave a Reply

Your email address will not be published. Required fields are marked *